Global In Vitro Diagnostics Market Analysis, Opportunities & Forecast During the Period, 2014-2024 - ResearchAndMarkets.com

DUBLIN--(BUSINESS WIRE)--The "Global In Vitro Diagnostics (IVD) Market: Analysis By Product (Medical Devices, Reagents and Kits, Services), By Technology, Application, End User, By Region, By Country (2019 Edition): Opportunities and Forecast (2014-2024)" report has been added to ResearchAndMarkets.com's offering.

Global In Vitro Diagnostics Market was valued at USD 61700.22 Million in the year 2018. As the size of the old age population is increasing globally, quality healthcare is required. Diagnostics have a major role, as the majority of clinical decisions are based on diagnostic test results. They assist in providing personalised treatment and drugs that are administered to the patient specifically. Additionally, the number of patients suffering from chronic and infectious disease are increasing globally, which is primarily powered by unhealthy lifestyles, air and water pollution, and genetic modification of disease causing microbes, which is estimated to accelerate the In Vitro Diagnostics Market Growth during the period of 2019-2024.

Molecular Diagnostics technology has been estimated to propel the market growth globally mainly because of large number of chronic diseases such as cancer, genetic disease, and Non Invasive Prenatal Testing. Also, End User growth rate of home test kits will be high due to ease of testing, cost effectiveness and accuracy of test results obtained. By product type, reagents and kits will have high growth rate, as they get consumed in the diagnostic process and have to be replenished. Also rising investment by leading IVD companies in development and automation of IVD products, according to disease specificity, has been anticipated to spur the market growth during the forecast period.

Key Topics Covered:

1. Report scope & Methodology

1.1 Scope of the Report

1.2 Research Methodology

1.3 Executive Summary

2. Strategic Recommendations

2.1 Focus on Theranostics

2.2 Investment in Microbiology system automation

2.3 Reducing the cost of diagnostic test

3. Global IVD Market: Product Outlook

4. Global In Vitro Diagnostics Market: An Analysis

4.1 Market Size, By Value, Year 2014-2024

5. Global In Vitro Diagnostics Segmentation By Technology (By Value)

5.1 Competitive Scenario of In Vitro Diagnostics: By Technology

5.2 Centralised and Point of Care - Market Size and Forecast (2019-2024)

5.3 Diabetes Care - Market Size and Forecast (2019-2024)

5.4 Molecular Diagnostics - Market Size and Forecast (2019-2024)

5.5 Tissue Diagnostics - Market Size and Forecast (2019-2024)

6. Global In Vitro Diagnostics Market Segmentation By Application (By Value)

6.1 Competitive Scenario of Global In Vitro Diagnostics: By Application

6.2 Infectious Disease - Market Size and Forecast (2019-2024)

6.3 Non Infectious Disease- Market Size and Forecast (2019-2024)

7.Global In Vitro Diagnostics Segmentation By End User (By Value)

7.1 Competitive Scenario of Global In Vitro Diagnostics: By End User

7.2 Hospitals - Market Size and Forecast (2019-2024)

7.3 Laboratory - Market Size and Forecast (2019-2024)

7.4 Home Test - Market Size and Forecast (2019-2024)

7.5 Others - Market Size and Forecast (2019-2024

8. Global In Vitro Diagnostics Segmentation By Products (By Value)

8.1 Competitive Scenario of Global In Vitro Diagnostics: By Products

8.2 Medical Devices - Market Size and Forecast (2019-2024)

8.3 Reagents and Kits - Market Size and Forecast (2019-2024)

8.4 Services - Market Size and Forecast (2019-2024)

9. Global In Vitro Diagnostics: Regional Analysis

9.1 Competitive Scenario of Global In Vitro Diagnostics: By Region

10. North America In Vitro Diagnostics Market: Segmentation By Technology, Application, End User, Products (2019-2024)

10.1 North America In Vitro Diagnostics Market: Size and Forecast (2019-2024)

10.2 North America In Vitro Diagnostics Market - Prominent Companies

10.3 Market Segmentation By Technology (Centralised & POC, Diabetes Care, Molecular Diagnostics, Tissue Diagnostics)

10.4 Market Segmentation By Application (Infectious Disease, Non Infectious Disease)

10.5 Market Segmentation By End User (Hospitals, Laboratory, Home Test, Others)

10.6 Market Segmentation By Products (Medical Devices, Reagents and Kits, Services)

10.7 North America In Vitro Diagnostics Market: Country Analysis

10.8 Market Opportunity Chart of North America In Vitro Diagnostics Market- By Country, By Value (Year-2024)

10.9 Competitive Scenario of North America In Vitro Diagnostics : By Country

10.10 United States In Vitro Diagnostics Market: Size and Forecast (2019-2024)

10.11 United States In Vitro Diagnostics Market Segmentation By Technology, Application, End User, Products (2019-2024)

10.12 Canada In Vitro Diagnostics Market: Size and Forecast (2019-2024)

10.13 Canada In Vitro Diagnostics Market Segmentation By Technology, Application, End User, Products (2019-2024)

10.14 Rest of North America In Vitro Diagnostics Market: Size and Forecast (2019-2024)

10.15 Rest of North America In Vitro Diagnostics Market Segmentation By Technology, Application, End User, Products (2019-2024)

11. Latin America In Vitro Diagnostics Market: Segmentation By Technology, Application, End User, Products (2019-2024)

14. Global In Vitro Diagnostics Market Dynamics

14.1 Global In Vitro diagnostic Market Drivers

14.2 Global In Vitro Diagnostic Market Restraints

14.3 Global In Vitro Diagnostic Market Trends

15. Market Attractiveness and Strategic Analysis

15.1 Market Attractiveness

15.1.1 Market Attractiveness Chart of Global In Vitro Diagnostics Market - By Technology (Year 2024)

15.1.2 Market Attractiveness Chart of Global In Vitro Diagnostics Market - By Application (Year 2024)

15.1.3 Market Attractiveness Chart of Global In Vitro Diagnostics Market - By End User (Year 2024)

15.1.4 Market Attractiveness Chart of Global In Vitro Diagnostics Market - By Products (Year 2024)

15.1.5 Market Attractiveness Chart of Global In Vitro Diagnostics Market - By Region (Year 2024)

15.2 Strategic Analysis

15.2.1 New Product Development

15.2.2 Key Developments in In Vitro Diagnostics Market

16. Competitive Landscape

16.1 Market Share Analysis

16.2 Competitive Positioning (Leaders, Challengers, Followers, Niche Players)

16.3 SWOT Analysis

16.4 Porter's Five Force Analysis

17. Company Analysis (Business Description, Financial Analysis, Business Strategy)

17.1 F. Hoffman-La Roche AG

17.2 Thermo Fisher Scientific

17.3 Sysmex

17.4 Abbott

17.5 Danaher

17.6 Siemens Healthineers

17.7 Biomerieux

17.8 Bio-Rad Laboratories

17.9 Becton Dickinson

17.10 Ortho Clinical Diagnostics

For more information about this report visit https://www.researchandmarkets.com/r/eglr5a